Annamaria Ruzzo
Overview
Explore the profile of Annamaria Ruzzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruzzo A, Graziano F, Palladino S, Fischer N, Catalano V, Giordani P, et al.
Oncologist
. 2024 Oct;
PMID: 39436921
Background: Clinical and experimental studies indicate that the tumor protein p53 (TP53) gene loss of function due to missense mutations (MMs) may confer sensitivity to anti-angiogenics. This effect seems to...
2.
Chiari R, Palladino S, Emili R, De Lisa M, Sarti D, Catalano V, et al.
Sci Rep
. 2023 Nov;
13(1):21036.
PMID: 38030703
KRAS is involved in the stability and expression of PD-L1. We investigated the expression of circulating mRNA (cmRNA) of KRAS4A and KRAS4B and the possible impact on progression-free survival (PFS)...
3.
Bagaloni I, Visani A, Biagiotti S, Ruzzo A, Navari M, Etebari M, et al.
Front Oncol
. 2021 Sep;
11:661102.
PMID: 34557403
Altered cellular energetic metabolism has recently emerged as important feature of neoplastic cells. Indeed, interfering with cancer cell metabolism might represent a suitable therapeutic strategy. In this study, we aimed...
4.
Loscocco F, Visani G, Ruzzo A, Bagaloni I, Fuligni F, Galimberti S, et al.
Front Oncol
. 2021 May;
11:672287.
PMID: 34055641
Tyrosine kinase inhibitors (TKIs) have radically changed the outcome of chronic myeloid leukemia (CML) patients in the last 20 years. Moreover, the advent of second generation TKIs, namely nilotinib and...
5.
Giulietti M, Bastianoni M, Cecati M, Ruzzo A, Bracci M, Malavolta M, et al.
Database (Oxford)
. 2020 Nov;
2020.
PMID: 33238004
The organotropism is the propensity of metastatic cancer cells to colonize preferably certain distant organs, resulting in a non-random distribution of metastases. In order to shed light on this behaviour,...
6.
Graziano F, Fischer N, Bagaloni I, Di Bartolomeo M, Lonardi S, Vincenzi B, et al.
Cancers (Basel)
. 2020 Jul;
12(8).
PMID: 32722340
Loss of p53 promotes vascular endothelial growth factor (VEGF)-A up-regulation and the angiogenic potential of cancer cells. We investigated somatic mutations in 110 primary gastric adenocarcinomas of two retrospective metastatic...
7.
Ruzzo A, Graziano F, Bagaloni I, Di Bartolomeo M, Prisciandaro M, Aprile G, et al.
Gastric Cancer
. 2020 May;
23(6):1064-1074.
PMID: 32372141
Introduction: For energy production, cancer cells maintain a high rate of glycolysis instead of oxidative phosphorylation converting glucose into lactic acid. This metabolic shift is useful to survive in unfavorable...
8.
Ruzzo A, Graziano F, Galli F, Galli F, Rulli E, Lonardi S, et al.
Sci Rep
. 2020 Feb;
10(1):1918.
PMID: 32005869
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
9.
Ruzzo A, Graziano F, Galli F, Galli F, Rulli E, Lonardi S, et al.
Sci Rep
. 2019 Aug;
9(1):11527.
PMID: 31395900
Polymorphisms contribute to inter-individual differences and show a promising predictive role for chemotherapy-related toxicity in colon cancer (CC). TOSCA is a multicentre, randomized, non-inferiority, phase III study conducted in high-risk...
10.
Visani G, Loscocco F, Bagaloni I, Ruzzo A, Fuligni F, Graziano F, et al.
Bone Marrow Transplant
. 2019 Jun;
55(4):818-820.
PMID: 31231123
No abstract available.